POC Diagnostics Market Size, Trends, Share, Growth, and Opportunity Forecast, 2025 - 2032 Global Industry Analysis By Type (Infectious Disease Testing, Cardiac Markers Testing, Blood Glucose Monitoring, Pregnancy & Fertility Testing, and Others), By Technology (Lateral Flow Assays, Molecular Diagnostics, Immunoassays, and Biosensors), By End-Use (Hospitals, Clinics, Home Care, and Laboratories), By Application (Clinical Diagnostics, Veterinary Diagnostics, Home Care Testing, and Drug Abuse Testing), and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

POC Diagnostics Market Report Overview

The Global POC Diagnostics Market was valued at USD 44.68 Billion in 2024 and is anticipated to reach a value of USD 68.50 Billion by 2032 expanding at a CAGR of 5.6% between 2025 and 2032. The rising frequency of chronic diseases such as diabetes and cardiovascular disorders, increased demand for rapid diagnostic tools, and a growing preference for home-based diagnostics are all key drivers of the POC diagnostics market.

To Learn More About This Report, Request A Free Sample Copy

The Point-of-Care Diagnostics (PoC) market is critical for providing rapid, on-the-spot diagnostic results across a wide range of healthcare settings. With the growing demand for more accessible and faster testing, particularly for chronic ailments such as diabetes and cardiovascular disease, point-of-care diagnostics have become an essential tool in modern healthcare. The industry offers a variety of testing options, including glucose monitoring, infectious illness detection, and cardiac indicators. POC diagnostics are growing more popular due to their simplicity and capacity to deliver real-time information, allowing for faster medical actions. With improvements in diagnostic technologies such as lateral flow assays and biosensors, the POC diagnostics market is expected to expand as more healthcare professionals and patients use these solutions in both clinical and home care settings. Medical technology innovations, such as AI integration, are enhancing the accuracy and speed of proof-of-concept testing, while cost-effective, portable solutions make diagnostics more accessible. Furthermore, the global COVID-19 epidemic has increased awareness and implementation of point-of-care diagnostics, resulting in growth across multiple healthcare areas.

How AI is Transforming POC Diagnostics Market

Artificial intelligence (AI) is transforming the point-of-care diagnostics market by increasing diagnostic accuracy, decreasing human error, and improving workflow efficiency. AI-powered algorithms may swiftly assess PoC test results, giving healthcare practitioners with real-time, data-driven insights to help them make faster clinical decisions. AI systems can comprehend complicated patterns from diagnostic devices such as glucose monitors and molecular testing kits, providing faster and more accurate results. Furthermore, AI-powered diagnostic tools are being connected with mobile health (mHealth) apps, enabling remote monitoring and management of chronic illnesses, so making healthcare more patient-centered.

AI also improves supply chain management for point-of-care diagnostic items by forecasting demand patterns based on healthcare trends and ensuring that tests are accessible when required. Furthermore, AI improves the security of patient data in diagnostics by employing encryption techniques, lowering the risk of cyber-attacks. With these improvements, AI is likely to remain a prominent growth element in the point-of-care diagnostics market, driving innovation and efficiency throughout the healthcare sector.

POC Diagnostics Market Major Driving Forces

·         Chronic Disease Prevalence: As chronic disorders such as diabetes and cardiovascular disease become more common, there is a greater desire for quick, easy diagnostic treatments.

·         Technological Advancements:  Technological advancements, such as lateral flow assays and molecular diagnostics, are increasing the accuracy and accessibility of PoC testing, hence driving market expansion.

·         Home-Based Care Adoption: A shift toward home healthcare, motivated by convenience and cost-effectiveness, is driving demand for portable diagnostic devices, hence growing the POC diagnostics market.

·         Aging Population: As the global aged population grows, there is a greater demand for regular monitoring and testing, which is driving the adoption of point-of-care diagnostics in hospital and home settings.

POC Diagnostics Market Key Opportunities

·         AI-Powered Diagnostics: Integrating AI into proof-of-concept devices improves diagnostic precision and opens up possibilities for remote healthcare monitoring, offering huge market expansion opportunities.

·         Expansion in Emerging Markets: As the demand for inexpensive healthcare and diagnostic solutions grows, developing regions in Asia Pacific, Latin America, and Africa provide significant growth prospects.

·         Wearable Diagnostic Devices: Innovations in wearable diagnostics, such as glucose monitors and cardiac sensors, are opening up new avenues for patient-centered care. These devices allow for real-time monitoring, which promotes proactive healthcare management and drives future growth in the POC diagnostics market.

POC Diagnostics Market Key Trends

·         The PoC Diagnostics Market has been witnessing a rising demand for home care diagnostics. As people choose to manage their health at home, the demand for portable, user-friendly point-of-care equipment is expanding.

·         The development of diagnostics based on individual genetic profiles and healthcare demands is a growing trend.

·         The combination of mobile health platforms with diagnostic equipment enables remote monitoring and improved patient outcomes, hence propelling the industry.

·         Eco-friendly proof-of-concept diagnostic options, such as biodegradable materials and energy-efficient gadgets, are emerging as a trend to lessen medical waste's environmental impact.  

Region-wise Market Insights

North America accounted for the largest market share at 35.4% in 2024 however, Asia Pacific is expected to register the fastest growth, expanding at a CAGR of 6.1% between 2025 and 2032.

To Learn More About This Report, Request A Free Sample Copy

North America dominated the point-of-care diagnostics market in 2024. The region's expansion is being driven by the availability of modern healthcare infrastructure, the prevalence of chronic diseases, and the use of novel diagnostic technology. The United States dominates the regional market due to considerable investments in R&D and the broad availability of proof-of-concept diagnostic devices.

·         In February 2025, Becton, Dickinson and Company announced its plan to separate its Biosciences and Diagnostic Solutions businesses. This move is aimed at enhancing focus, driving growth, and unlocking value for shareholders. The separation will enable each business to pursue its growth opportunities more effectively and maximize its potential.

Asia Pacific is predicted to be the fastest-growing area, with a 6.1% CAGR between 2025 and 2032. The region's expansion is being driven by increased healthcare investments, increased awareness of early disease detection, and a growing desire for low-cost diagnostic options. China and India have made significant contributions to this expansion through increased healthcare access and technology improvements.

Precision medicine and tailored diagnostics are becoming increasingly popular in Europe, which is driving market growth. Meanwhile, Latin America, the Middle East, and Africa are steadily boosting their healthcare infrastructure investments, opening up new potential for point-of-care diagnostic technologies.

Recent Developments

·         In August 2024, Roche finalized its acquisition of LumiraDx's point-of-care (POC) technology, enhancing its diagnostic capabilities. This acquisition allows Roche to integrate innovative technologies into its portfolio, focusing on improving rapid diagnostic testing and healthcare delivery.

·         In April 2024, Roche Diagnostics India launched the NT-proBNP test for diabetes patients at risk of cardiovascular disease (CVD). This test aids in early detection, helping healthcare providers assess heart failure risk in diabetic patients, allowing for timely intervention. The test is designed to enhance the diagnosis and management of CVD in this high-risk group.

·         In May 2023, QuidelOrtho showcased innovative point-of-care diagnostic solutions at the EuroMedLab 2023 event. These advancements highlight the company's commitment to providing fast, accurate diagnostic tools aimed at improving patient care and clinical outcomes. For more details, you can view the full coverage here.

·         In January 2022, Abbott showcased its life-changing point-of-care (POC) tests and diagnostic tools at Medlab Middle East. The company highlighted innovations aimed at improving patient outcomes with rapid, accurate diagnostics. These tools are designed to address various health challenges, particularly in critical care settings. For more information, you can visit the full article here.

Market Competition Landscape

The global point-of-care diagnostics market is fiercely competitive, with top businesses consistently innovating to obtain a competitive advantage. Major competitors such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers lead the industry with a diverse variety of diagnostic products. These companies concentrate on extending their product portfolios through R&D and strategic partnerships. The integration of AI technology, together with the increased demand for home-based care, has driven these companies to develop mobile and portable diagnostics.

 In addition to established industry leaders, smaller regional businesses and startups are entering the market with specialised solutions, particularly in personalised diagnostics and telemedicine-integrated testing. The competitive field is growing more congested as companies prioritize sustainability and efficiency in their proof-of-concept diagnostic solutions to suit changing market demands.

Key players in the global Poc Diagnostics market implement various organic and inorganic strategies to strengthen and improve their market positioning. Prominent players in the market include:

·         Abbott Laboratories

·         Roche Diagnostics

·         Siemens Healthineers

·         Danaher Corporation

·         Becton, Dickinson and Company

·         QuidelOrtho Corporation

·         bioMérieux

·         Chembio Diagnostics

·         PerkinElmer

·         Bio-Rad Laboratories

·         Thermo Fisher Scientific

·         Sysmex Corporation

·         Trividia Health

·         Nova Biomedical